No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1

被引:9
|
作者
Koning, FA
Schols, D
Schuitemaker, H
机构
[1] CLB Sanquin, Dept Clin Viroimmunol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Expt & Clin Immunol Lab, NL-1105 AZ Amsterdam, Netherlands
[3] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, B-3000 Louvain, Belgium
关键词
D O I
10.1128/JVI.75.18.8848-8853.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In two cases of parenteral transmission of human immunodeficiency virus type 1 (HIV-1) syncitium-inducing (SI) variants, we previously observed selection for macrophagetropic variants. Although infection of macrophages is generally mediated via CCR5, we found no selection for SI variants that could use CCR5 as coreceptor in addition to CXCR4, suggesting that features other than coreceptor usage account for the macrophagetropism of these transmitted SI HIV-1 variants.
引用
收藏
页码:8848 / 8853
页数:6
相关论文
共 50 条
  • [1] CCRS/△ccr5 heterozygosity:: A selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype
    D'Aquila, RT
    Sutton, L
    Savara, A
    Hughes, MD
    Johnson, VA
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06): : 1549 - 1553
  • [2] Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
    Doranz, BJ
    Lu, ZH
    Rucker, J
    Zhang, TY
    Sharron, M
    Cen, YH
    Wang, ZX
    Guo, HH
    Du, JG
    Accaviti, MA
    Doms, RW
    Peiper, SC
    JOURNAL OF VIROLOGY, 1997, 71 (09) : 6305 - 6314
  • [3] Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities
    Guillon, C
    van der Ende, ME
    Boers, PHM
    Gruters, RA
    Schutten, M
    Osterhaus, ADME
    JOURNAL OF VIROLOGY, 1998, 72 (07) : 6260 - 6263
  • [4] Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either lestr or CCR5 as coreceptors for virus entry
    Simmons, G
    Wilkinson, D
    Reeves, JD
    Dittmar, MT
    Beddows, S
    Weber, J
    Carnegie, G
    Desselberger, U
    Gray, PW
    Weiss, RA
    Clapham, PR
    JOURNAL OF VIROLOGY, 1996, 70 (12) : 8355 - 8360
  • [5] Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1
    Hunt, Joshua S.
    Romanelli, Frank
    PHARMACOTHERAPY, 2009, 29 (03): : 295 - 304
  • [6] Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency viruses during primary infection
    Rodrigo, AG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (17) : 1447 - 1451
  • [7] Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage
    Teeravechyan, Samapom
    Suphaphiphat, Pirada
    Essex, Max
    Lee, Tun-Hou
    VIROLOGY, 2008, 370 (02) : 443 - 450
  • [8] QUANTITATIVE-ANALYSIS OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING VIRUS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SHAFER, RW
    AGUINIGA, E
    MERIGAN, TC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) : 212 - 214
  • [9] Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection
    van't Wout, AB
    Blaak, H
    Ran, LJ
    Brouwer, M
    Kuiken, C
    Schuitemaker, H
    JOURNAL OF VIROLOGY, 1998, 72 (06) : 5099 - 5107
  • [10] CCR2-641 polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression
    Vicenzi, E
    Ghezzi, S
    Brambilla, A
    Sheppard, HW
    Lazzarin, A
    Poli, G
    Michael, NL
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05): : 1579 - 1580